Rapid determination of remdesivir (SARS-CoV-2 drug) in human plasma for therapeutic drug monitoring in COVID-19-Patients

To tackle the harmful consequences of the widespread COVID-19 pandemic, a broad-spectrum anti-viral drug remdesivir (RDV) has gained the utmost attention recently due to its promising application in treating COVID-19 patients. However, a fast and sensitive analytical methodology is important to moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasupuleti, Raghavendra Rao, Tsai, Pei-Chien, Ponnusamy, Vinoth Kumar, Pugazhendhi, Arivalagan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762619/
https://www.ncbi.nlm.nih.gov/pubmed/33390763
http://dx.doi.org/10.1016/j.procbio.2020.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762619/
https://www.ncbi.nlm.nih.gov/pubmed/33390763
http://dx.doi.org/10.1016/j.procbio.2020.12.014

Ejemplares similares